Clinical Trials Browser

Phase 1 × Neoplasm Metastasis × trebananib × Clear all

NCT00807859 2022-11-08

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00770536 2015-09-29

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Phase 1 Completed

Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms

NCT00102830 2010-08-20

Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasm Metastasis, Neoplasms